Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Oncogenesis
SJR: 0.631 SNIP: 0.503 CiteScore™: 2.2

ISSN Печать: 0893-9675
ISSN Онлайн: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.v16.i1-2.100
pages 103-115

Targeting NOTCH1 in Hematopoietic Malignancy

Giovanni Roti
Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02215, USA
Kimberly Stegmaier
Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts

Краткое описание

NOTCH1 is a well-validated target in hematopoietic malignancy, with NOTCH1 activating mutations identified in more than 50% of T-cell acute lymphoblastic leukemias. Moreover, a recent report has identified NOTCH1 activating mutations in 12% of chronic lymphocytic leukemias. While the frequency of NOTCH1 mutations and the well-documented role of this protein in the pathogenesis and maintenance of T-ALL support targeting NOTCH1 as a therapeutic strategy, the critical role of this protein in normal cell-fate specification and differentiation lead to complexities in its successful targeting. In this review, we will discuss potential approaches to targeting NOTCH1 in hematopoietic malignancies, including inhibition of the enzymes involved in its activation, antibodies directed against either the receptor or its ligands, and direct interference with the NOTCH1 transcriptional complex. Moreover, we will discuss the challenges to each of these approaches as well as potential solutions to overcoming these difficulties.

Articles with similar content:

Friend or Foe: Can Activating Mutations in NOTCH1 Contribute to a Favorable Treatment Outcome in Patients with T-ALL?
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 5
Michael Berger, Aviya Goldshtein
MHC Transfer from APC to T Cells Following Antigen Recognition
Critical Reviews™ in Immunology, Vol.26, 2006, issue 1
Scott A. Wetzel, David C. Parker
Modulation of Innate Immune Responses by Hantaviruses
Critical Reviews™ in Immunology, Vol.30, 2010, issue 6
Andreas Rang
Diagnostic, Prognostic, and Therapeutic Potencies of Circulating miRNAs in Acute Myocardial Infarction
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 4
Farshad Mirzavi, Seyed Mahdi Hassanian Mehr, Seyed Isaac Hashemy, Kiarash Ghazvini, Safieh Ebrahimi
Roles of Steroid Receptor Coactivator 3 in Host Defense Against Bacterial Pathogens
Critical Reviews™ in Immunology, Vol.38, 2018, issue 3
Pingli Mo, Chundong Yu, Wenbo Chen